Chemical Compound
Reboxetine Mesilate; Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-, methanesulfonate (9CI); Davedax; Edronax; FCE 20124; PNU 155905E; PNU 155950E; Reboxetine mesilate; Reboxetine mesylate; Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-, methanesulfonate (1:1); Morpholine, 2-[(2-ethoxyphenoxy)phenylmethyl]-, (R*,R*)-(+/-)-, methanesulfonate; (+/-) Reboxetine mesylate
CAS Registry Number
98769-84-7
Primary record
Reboxetine Mesilate; Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-, methanesulfonate (9CI); Davedax; Edronax; FCE 20124; PNU 155905E; PNU 155950E; Reboxetine mesilate; Reboxetine mesylate; Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-, methanesulfonate (1:1); Morpholine, 2-[(2-ethoxyphenoxy)phenylmethyl]-, (R*,R*)-(+/-)-, methanesulfonate; (+/-) Reboxetine mesylate
- 库存
- 1,229 克
- 纯度
- 98.5 %
- CAS
- 98769-84-7
化合物标识与属性
- CAS
- 98769-84-7
- PubChem CID
- 127150
- SMILES
- CCOC1=CC=CC=C1O[C@@H]([C@H]2CNCCO2)C3=CC=CC=C3.CS(=O)(=O)O
- Canonical SMILES
- CCOc1ccccc1O[C@H](c1ccccc1)[C@H]1CNCCO1.CS(=O)(=O)O
名称与同义词
- Reboxetine mesylate
- Edronax
- Reboxetine mesilate
- Reboxetine
- 98769-84-7
- Prolift
- Vestra
- Reboxitine
- Davedax
- Reboxetine (mesylate)
- Reboxetine mesylate;
- Vestra (TN)
- Prolift;Vestra;Norebox
- Reboxetine mesylate [USAN]
- L94J81YNNY
- Reboxetine methansulphonate
- REBOXETINE METHANESULFONATE
- Reboxetine methanesulphonate
- UNII-L94J81YNNY
- Reboxetine [INN:BAN]
- (R,R)-reboxetine (mesylate)
- AC1L2RIX
- AC1Q6WCV
- RefChem:178708
- DTXSID8045690
- FCE 20124
- (R,R)-Reboxetine mesylate
- Reboxetine.methanesulfonic acid
- PNU 155950E
- C20H27NO6S
- Reboxetine mesylate (USAN)
- (+/-)-Reboxetine Mesylate
- MFCD02184016
- DTXCID6025690
- (S,S)-reboxetine (mesylate)
- PNU-155950E
- SCHEMBL260136
- UNII-947S0YZ36I
- orb1300308
- orb1745058
- C19H23NO3.CH4O3S
- CHEMBL2105282
- CTK8G2917
- HSDB 7701
- MSK11177S
- AOB2309
- FCE-20124
- Reboxetine (mesylate) (Standard)
- BH007
- GLXC-04178
- HMS3885G13
- HY-14560CR
- KST-1A0218
- REBOXETINE MESYLATE [VANDF]
- ACT10901
- PNU 155905E
- REBOXETINE MESILATE [MART.]
- Tox21_110964
- AR-1A0202
- CID127150
- CR0014
- EBC-80031
- FC0011
- HY-14560A
- REBOXETINE MESILATE [WHO-DD]
- s3199
- AKOS015895146
- Tox21_110964_1
- ACN-048277
- CCG-268759
- FR27687
- M20R898
- Reboxetine mesylate - Bio-X trade mark
- REBOXETINE METHANESULFONATE [MI]
- NCGC00025335-01
- NCGC00263541-01
- 105017-39-8
- AN-15040
- AS-15081
- BR164331
- DA-48796
- DA-67136
- LS-93006
- N926
- C19-H23-N-O3.C-H4-O3-S
- AB0016142
- CAS-98769-84-7
- FCE20124 mesylate;PNU155950E mesylate
- B2124
- CS-0007921
- SW219318-1
- 71620-89-8
- (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine;methanesulfonic acid
- (R)-2-((R)-(2-ethoxyphenoxy)(phenyl)methyl)morpholine methanesulfonate
- A11919
- D02573
- A845908
- 141425-90-3
- 93851-87-7
- I06-1282
- Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-,methanesulfonate
- 2-((2-ethoxyphenoxy)benzyl)morpholine methanesulfonate
- Q27282861
- 98769-82-5
- 2-((2-Ethoxyphenoxy)phenylmethyl)morpholine methanesulfonate
- B2694-158042
- Reboxetine Mesilate 1.0 mg/ml in Methanol (as free base)
- ( inverted exclamation markA)-(2r*)-2-[(ar*)-a-(o-ethoxyphenoxy)benzyl]morpholine methanesulfonate
- (2R)-2-[(R)-(2-ethoxyphenoxy)-phenyl-methyl]morpholine; methanesulfonic acid
- (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine; methanesulfonic acid
- (2R)-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine mesylate
- (2R)-rel-2-[(R)-(2-Ethoxyphenoxy)phenylmethyl]morpholine Methanesulfonate
- 2-((2-Ethoxyphenoxy)(phenyl)methyl)morpholine methanesulfonate
- 98819-77-3
- Morpholine, 2-((2-ethoxyphenoxy)phenylmethyl)-, methanesulfonate
- rel-(R)-2-((R)-(2-Ethoxyphenoxy)(phenyl)methyl)morpholine mesylate
- (+-)-(R*,S*)-2-((2-Ethoxyphenoxy)phenylmethyl)morpholine methanesulfonate
- (R)-2-((R)-(2-ethoxyphenoxy)(phenyl)methyl)morpholinemethanesulfonate
- 6284-04-4
- (+-)-(2R*)-2-((alphaS*)-alpha-(o-Ethoxyphenoxy)benzyl)morpholine methanesulfonate
- (+/-)-(R*,S*)-2-((2-ETHOXYPHENOXY)PHENYLMETHYL)MORPHOLINE METHANESULFONATE
- (+/-)-(R*,S*)-2-((2-ETHOXYPHENOXY)PHENYLMETHYL)MORPHOLINE METHANESULPHONATE
- (2R)-2-[(R)-(2-ethoxyphenoxy)-phenyl-methyl]morpholine;methanesulfonic acid
- Methanesulfonic acid--(2R)-2-[(R)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine (1/1)
- Morpholine, 2-((2-ethoxyphenoxy)phenylmethyl)-, (R*,R*)-(+-)-, methanesulfonate
- Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-rel-, methanesulfonate
- Morpholine, 2-[(S)-(2-ethoxyphenoxy)phenylmethyl]-, (2S)-, methanesulfonate (1:1)
- rel-(R)-2-((R)-(2-ethoxyphenoxy)(phenyl)methyl)morpholine methanesulfonate(1:1)
- (+/-)-(2R*)-2-((.ALPHA.S*)-.ALPHA.-(O-ETHOXYPHENOXY)BENZYL)MORPHOLINE METHANESULFONATE
- (+/-)-(2R*)-2-((.ALPHA.S*)-.ALPHA.-(O-ETHOXYPHENOXY)BENZYL)MORPHOLINE METHANESULPHONATE
- Reboxetine Mesilate; Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-, methanesulfonate (9CI); Davedax; Edronax; FCE 20124; PNU 155905E; PNU 155950E; Reboxetine mesilate; Reboxetine mesylate; Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-, methanesulfonate (1:1); Morpholine, 2-[(2-ethoxyphenoxy)phenylmethyl]-, (R*,R*)-(+/-)-, methanesulfonate; (+/-) Reboxetine mesylate